Pharmena S.A. (PHR) - Total Liabilities

Latest as of September 2025: zł850.00K PLN ≈ $233.93K USD

Based on the latest financial reports, Pharmena S.A. (PHR) has total liabilities worth zł850.00K PLN (≈ $233.93K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Pharmena S.A. cash flow conversion to assess how effectively this company generates cash.

Pharmena S.A. - Total Liabilities Trend (2008–2024)

This chart illustrates how Pharmena S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check PHR asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Pharmena S.A. Competitors by Total Liabilities

The table below lists competitors of Pharmena S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
SaveLend Group AB ST:YIELD	Sweden	Skr266.65 Million
SONOKONG Co. Ltd KQ:066910	Korea	₩70.61 Billion
Tonkens Agrar AG XETRA:GTK	Germany	€27.89 Million
Quoin Pharmaceuticals Ltd DRC NASDAQ:QNRX	USA	$7.64 Million
ERWE Immobilien AG F:ERWE	Germany	€186.90 Million
Marine Petroleum Trust NASDAQ:MARPS	USA	$0.00
Baru Gold Corp V:BARU	Canada	CA$8.91 Million
Buxton Resources Ltd AU:BUX	Australia	AU$637.87K

Liability Composition Analysis (2008–2024)

This chart breaks down Pharmena S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PHR market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	13.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmena S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmena S.A. (2008–2024)

The table below shows the annual total liabilities of Pharmena S.A. from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	zł1.11 Million ≈ $304.39K	-41.97%
2023-12-31	zł1.91 Million ≈ $524.56K	-90.16%
2022-12-31	zł19.37 Million ≈ $5.33 Million	+19.04%
2021-12-31	zł16.27 Million ≈ $4.48 Million	+44.03%
2020-12-31	zł11.30 Million ≈ $3.11 Million	+67.53%
2019-12-31	zł6.74 Million ≈ $1.86 Million	+38.57%
2018-12-31	zł4.87 Million ≈ $1.34 Million	-35.47%
2017-12-31	zł7.54 Million ≈ $2.08 Million	-9.57%
2016-12-31	zł8.34 Million ≈ $2.30 Million	+28.60%
2015-12-31	zł6.49 Million ≈ $1.78 Million	+71.61%
2014-12-31	zł3.78 Million ≈ $1.04 Million	+50.80%
2013-12-31	zł2.51 Million ≈ $689.69K	-3.98%
2012-12-31	zł2.61 Million ≈ $718.31K	+63.31%
2011-12-31	zł1.60 Million ≈ $439.83K	+75.05%
2010-12-31	zł912.97K ≈ $251.26K	-2.34%
2009-12-31	zł934.89K ≈ $257.29K	+27.15%
2008-12-31	zł735.26K ≈ $202.35K	--

About Pharmena S.A.

WAR:PHR Poland Biotechnology

Market Cap

$10.02 Million

zł36.42 Million PLN

Market Cap Rank

#26878 Global

#284 in Poland

Share Price

zł3.27

Change (1 day)

-1.51%

52-Week Range

zł2.55 - zł4.37

All Time High

zł28.01